Emergent Biosolutions EBS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The official record: Emergent Biosolutions’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's return on equity?
- Emergent Biosolutions (EBS) reported return on equity of 13.9% in Q3 2025.
- How has Emergent Biosolutions's return on equity changed year-over-year?
- Emergent Biosolutions's return on equity increased by 140.2% year-over-year, from -34.6% to 13.9%.
- What is the long-term trend for Emergent Biosolutions's return on equity?
- Over 4 years (2020 to 2024), Emergent Biosolutions's return on equity has grown at a 8.8% compound annual growth rate (CAGR), from 24% to -33.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.